Assessing social preferences in reimbursement negotiations for new Pharmaceuticals in Oncology: an experimental design to analyse willingness to pay and willingness to accept

Assessing social preferences in reimbursement negotiations for new Pharmaceuticals in Oncology: an experimental design to analyse willingness to pay and willingness to accept

Abstract Background Price negotiations for specialty pharmaceuticals take place in a complex market setting. The determination of the added value of new treatments and the related societal willingness to pay are of increasing importance in policy reform debates. From a behavioural economics perspect...

Full description

Bibliographic Details
Main Authors: Dominik J. Wettstein, Stefan Boes
Format: Article
Language:English
Published: BMC 2021-03-01
Series:BMC Health Services Research
Subjects:
Willingness to pay
Willingness to accept
QALY
Medicines regulation
Pharmaceutical policies
Value-based pricing
Online Access:https://doi.org/10.1186/s12913-021-06231-8

Internet

https://doi.org/10.1186/s12913-021-06231-8

Similar Items